Xialin Wu

Hybrid neural network approaches to predict drug–target binding affinity for drug repurposing: screening for potential leads for Alzheimer’s disease

Guanxing Chen, Calvin Yu‐Chian Chen, Xialin Wu, 2023, Frontiers in Molecular Biosciences.